$26.35 0.00 (0%)
9/27/2010 4:01 PM

Biovail Corp (USA) (NYSE:BVF.DL)

CAPS Rating: No stars

A specialty pharmaceutical company that applies advanced drug-delivery technologies to improve the clinical effectiveness of medicines. Its main therapeutic areas are central nervous system disorders, pain management and cardiovascular disease.

Recs

0
Player Avatar RxBodie (< 20) Submitted: 12/23/2007 8:57:19 PM : Outperform Start Price: $13.03 BVF.DL Score: +0.63

Beaten down too far too fast. Generic business doing well. Branded products are losing patent protection but I feel it is already baked into the price. Dividend is very high for the time being.

Report this Post Add Comment

Featured Broker Partners


Advertisement